LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 45.25 | 84.90 | 4644 | 4539 | 1.0229 | 1.0079 | MN20160318_Q02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 45.25 | 84.90 | 4710 | 4539 | 1.0375 | 1.0129 | MN20160318_Q02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 45.25 | 84.90 | 4418 | 4539 | 0.9732 | 0.9905 | MN20160318_Q02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 45.25 | 84.90 | 4473 | 4539 | 0.9853 | 0.9948 | MN20160318_Q02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 46.95 | 84.90 | 4946 | 4952 | 0.9987 | 0.9996 | MN20160318_Q02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 46.95 | 84.90 | 5019 | 4952 | 1.0134 | 1.0045 | MN20160318_Q02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 46.95 | 84.90 | 4801 | 4952 | 0.9694 | 0.9894 | MN20160318_Q02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 46.95 | 84.90 | 4852 | 4952 | 0.9797 | 0.9930 | MN20160318_Q02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 48.65 | 84.90 | 5227 | 5328 | 0.9809 | 0.9936 | MN20160318_Q02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 48.65 | 84.90 | 5314 | 5328 | 0.9972 | 0.9991 | MN20160318_Q02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 48.65 | 84.90 | 5040 | 5328 | 0.9458 | 0.9814 | MN20160318_Q02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 48.65 | 84.90 | 5095 | 5328 | 0.9561 | 0.9850 | MN20160318_Q02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 50.36 | 84.90 | 5584 | 5651 | 0.9881 | 0.9961 | MN20160318_Q02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 50.36 | 84.90 | 5685 | 5651 | 1.0060 | 1.0020 | MN20160318_Q02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 50.36 | 84.90 | 5342 | 5651 | 0.9453 | 0.9815 | MN20160318_Q02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 50.36 | 84.90 | 5394 | 5651 | 0.9545 | 0.9847 | MN20160318_Q02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 52.06 | 84.90 | 5903 | 5990 | 0.9853 | 0.9952 | MN20160318_Q02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 52.06 | 84.90 | 6041 | 5990 | 1.0084 | 1.0027 | MN20160318_Q02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 52.06 | 84.90 | 5638 | 5990 | 0.9411 | 0.9803 | MN20160318_Q02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 52.06 | 84.90 | 5692 | 5990 | 0.9501 | 0.9834 | MN20160318_Q02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 53.77 | 84.90 | 6115 | 6252 | 0.9780 | 0.9928 | MN20160318_Q02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 53.77 | 84.90 | 6260 | 6252 | 1.0012 | 1.0004 | MN20160318_Q02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 53.77 | 84.90 | 5990 | 6252 | 0.9580 | 0.9862 | MN20160318_Q02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 53.77 | 84.90 | 6054 | 6252 | 0.9682 | 0.9896 | MN20160318_Q02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 55.48 | 84.90 | 6449 | 6567 | 0.9819 | 0.9942 | MN20160318_Q02 | G05 |